Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Cytokinetics Insider Sold Shares Worth $702,400, According to a Recent SEC Filing

Cytokinetics Insider Sold Shares Worth $702,400, According to a Recent SEC Filing

MT newswireMT newswire2026/08/31 21:03
05:03 PM EDT, 08/31/2026 (MT Newswires) -- Andrew Callos, Executive Vice President, Chief Commercial Officer, on August 31, 2026, sold 10,000 shares in Cytokinetics (CYTK) for $702,400. Following the Form 4 filing with the SEC, Callos has control over a total of 58,555 common shares of the company, with 58,555 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Global bond market sell-off intensifies! Australian bond yields hit a fifteen-year high as traders bet on Reserve Bank of Australia resuming rate hikes soon

Due to intensified global sovereign bond sell-offs and domestic inflation and consumption data continuously exceeding expectations, Australia’s benchmark government bond yield has risen to its highest level since 2011.

智通财经2026/09/01 03:47
Global bond market sell-off intensifies! Australian bond yields hit a fifteen-year high as traders bet on Reserve Bank of Australia resuming rate hikes soon